SRP54-AS1: A Potential Drug Target and Biomarker (G100506157)

Target Name: SRP54-AS1

NCBI ID: G100506157

SRP54-AS1

Other Name(s): SRP54 antisense RNA 1

SRP54-AS1: A Potential Drug Target and Biomarker

SRP54-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a heat shock protein (HSP) that is involved in the regulation of cellular stress responses. HSPs are a family of proteins that are able to withstand high levels of temperature and other forms of stress, and they play a crucial role in maintaining the stability and integrity of cellular structures.

One of the unique features of SRP54-AS1 is its ability to interact with other proteins that are involved in the stress response pathway. This interaction allows the protein to influence the activity of these other proteins, and suggests that it may be a useful drug target.

In addition to its potential as a drug target, SRP54-AS1 has also been identified as a potential biomarker for a variety of diseases. For example, it has been shown to be elevated in the brains of individuals with Alzheimer's disease, and it has been linked to an increased risk of certain heart diseases.

The discovery and characterization of SRP54-AS1 as a potential drug target and biomarker is an exciting development in the field of neurodegenerative diseases. This protein has the potential to be used to develop new treatments for a variety of conditions, including Alzheimer's disease, heart disease, and other forms of neurodegeneration.

In conclusion, SRP54-AS1 is a protein that has the potential to be a drug target and biomarker for a variety of neurodegenerative diseases. Further research is needed to fully understand its functions and to develop effective treatments based on its unique properties.

Protein Name: SRP54 Antisense RNA 1

The "SRP54-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRP54-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets